相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
Jianda Yuan et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
Aaron S. Mansield et al.
ONCOIMMUNOLOGY (2013)
Use of S-100B to Evaluate Therapy Effects during Bevacizumab Induction Treatment in AJCC Stage III Melanoma
S. Kruijff et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer
John Dulos et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
Alicia Gonzalez-Martin et al.
CANCER RESEARCH (2011)
Differential Response of Human and Mouse Dendritic Cells to VEGF Determines Interspecies Discrepancies in Tumor-Mediated Th1/Th2 Polarity Shift
Matthew S. Block et al.
CLINICAL CANCER RESEARCH (2011)
Update on the Melanoma Staging System: The Importance of Sentinel Node Staging and Primary Tumor Mitotic Rate
Charles M. Balch et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis
Aaron S. Mansfield et al.
MODERN PATHOLOGY (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Tumor Cell Expression of Programmed Cell Death-1 Ligand 1 Is a Prognostic Factor for Malignant Melanoma
Ryosuke Hino et al.
CANCER (2010)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Distinct Roles of Vascular Endothelial Growth Factor Receptor-1-and Receptor-2-Mediated Signaling in T Cell Priming and Th17 Polarization to Lipopolysaccharide-Containing Allergens in the Lung
You-Sun Kim et al.
JOURNAL OF IMMUNOLOGY (2010)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
Wendy K. Nevala et al.
CLINICAL CANCER RESEARCH (2009)
A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update
S. Biswas et al.
ECANCERMEDICALSCIENCE (2008)
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma
Kimberly A. Varker et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection
Patricia Ngai et al.
INFECTION AND IMMUNITY (2007)
Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma
Rebecca J. Critchley-Thorne et al.
PLOS MEDICINE (2007)
Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma
Hitoe Torisu-Itakura et al.
CLINICAL CANCER RESEARCH (2007)
Regional node dissection for melanoma: Techniques and indication
James W. Jakub et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Tumour immunology - Tumour-induced immune modulation of sentinel lymph nodes
Alistair J. Cochran et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung
CG Lee et al.
NATURE MEDICINE (2004)
Immunologic escape and angiogenesis in human malignant melanoma
P Redondo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity
S Sebastiani et al.
JOURNAL OF IMMUNOLOGY (2001)